Clinical Profiles in Multiple Sclerosis : Cognitive Reserve and Motor Impairment along Disease Duration

(i) Background: Cognitive impairment in people with multiple sclerosis (MS) has been studied in relation to certain clinical variables (e.g., motor disability and disease duration) and lifestyle factors such as cognitive reserve (CR). However, only very few studies have considered the interaction of clinical variables and cognitive reserve in preserving the integrity of the neuropsychological profile. In this paper, we hypothesised that a higher level of CR might predict good cognitive efficiency by modulating the clinical outcome of the disease. (ii) Methods: A sample of 100 participants with MS (age range 30-74), was recruited and assessed remotely with a questionnaire to measure CR and a cognitive screening test. Data were analysed through generalized additive models. (iii) Results: We found that the model analysing the interaction between CR and disease duration, and between CR and motor disability, was able to explain a significant percentage of cognitive performance. In particular, higher levels of CR predicted a better cognitive performance despite a long disease duration, unless the motor disability was severe. (iv) Conclusion: This study highlights the crucial role of CR in modulating cognitive efficiency in people with MS.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Behavioral sciences (Basel, Switzerland) - 13(2023), 9 vom: 25. Aug.

Sprache:

Englisch

Beteiligte Personen:

Maffezzini, Sabrina [VerfasserIn]
Pucci, Veronica [VerfasserIn]
Riccardi, Alice [VerfasserIn]
Montemurro, Sonia [VerfasserIn]
Puthenparampil, Marco [VerfasserIn]
Perini, Paola [VerfasserIn]
Rinaldi, Francesca [VerfasserIn]
Gallo, Paolo [VerfasserIn]
Arcara, Giorgio [VerfasserIn]
Mondini, Sara [VerfasserIn]

Links:

Volltext

Themen:

Cognitive impairment
Cognitive reserve
Disease duration
Generalised additive models
Journal Article
Motor impairment
Multiple sclerosis

Anmerkungen:

Date Revised 03.10.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/bs13090708

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM362503117